Ensysce Biosciences Inc (ENSC)

9.36 -0.62 (-6.21%) USD  |  NASDAQ  |  Dec 26, 16:00
9.42 +0.06 (+0.64%) After-Hours: 20:00
More

Ensysce Biosciences Enterprise Value: 8.928M for Dec. 24, 2024

Enterprise Value Chart

View Enterprise Value for ENSC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Genprex Inc 6.409M
IN8bio Inc 13.00M
Sensei Biotherapeutics Inc -35.58M
NovaBay Pharmaceuticals Inc 1.919M
Palatin Technologies Inc 16.97M

Enterprise Value Related Metrics

Net Income (Quarterly) 0.6618M
Total Expenses (Quarterly) -0.6447M
EPS Diluted (Quarterly) 1.05
Earnings Yield -322.1%